RxDoctor Payments DataLook up a doctor →

Mandy Gordon

Nurse Practitioner · Jonesboro, ARNPI 1497195598

Payments from drug & device makers

$12,198in general payments, 2019–2025

Across 573 payments — averaging $21.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Daiichi Sankyo Inc.$2K
  • AstraZeneca$1K
  • Johnson & Johnson$1K
  • Novartis$791
  • Incyte Corporation$581
  • GSK$490
  • plus $6K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Daiichi Sankyo Inc.37$1,733
AstraZeneca(2 entities)42$1,099
Johnson & Johnson(2 entities)51$1,094
Novartis51$791
Incyte Corporation19$581
GSK25$490
AbbVie23$483
Merck23$441
Amgen26$436
Eisai Inc.23$405
Pfizer27$399
Sanofi14$246
Takeda Pharmaceuticals U.S.A., Inc.11$222
Exelixis Inc.14$219
Seagen Inc.10$215
Lilly USA, LLC12$194
Puma Biotechnology, Inc.11$176
E.r. Squibb & Sons, L.L.C.6$163
Pharmacyclics LLC, An Abbvie Company7$157
Regeneron Healthcare Solutions, Inc.7$142
AVEO Pharmaceuticals, Inc.8$136
Genentech USA, Inc.9$132
EMD Serono, Inc.3$129
Ipsen Biopharmaceuticals, Inc9$126
Stemline Therapeutics Inc.1$124
Boehringer Ingelheim5$119
Bayer7$115
Sobi, Inc6$106
Deciphera Pharmaceuticals Inc.6$105
Bristol Myers Squibb7$103
Astellas Pharma US Inc6$101
ADC Therapeutics America, Inc.6$91
Mirati Therapeutics, Inc.1$86
Beigene USA, Inc.5$81
Tersera Therapeutics LLC3$73
Beone Medicines USA, Inc.4$72
Dova Pharmaceuticals5$68
Pharmacosmos Therapeutics Inc.2$66
Pharmaessentia USA Corporation3$53
Iovance Biotherapeutics, Inc.3$50
Array Biopharma Inc3$47
Janssen Scientific Affairs, LLC1$47
Apellis Pharmaceuticals, Inc.2$46
G1 Therapeutics, Inc.3$44
Kyowa Kirin, Inc.2$38
Alnylam Pharmaceuticals Inc.2$36
Myovant Sciences Inc.2$36
Rigel Pharmaceuticals, Inc.3$35
Caris MPI, Inc.2$34
Dendreon Pharmaceuticals LLC2$30
Acceleron Pharma, Inc.2$23
Tempus AI, Inc1$20
UCB, Inc.1$18
Gilead1$16
Karyopharm Therapeutics Inc.1$15
AMAG Pharmaceuticals, Inc.1$15
Syndax Pharmaceuticals, Inc.1$14
Global Blood Therapeutics, Inc.1$13
Sumitomo Pharma America, Inc.1$13
Boston Scientific1$13

How this compares

$12,198 in reported general payments places this provider in the 95th percentile of 697 nurse practitioner providers in Arkansas.

See all nurse practitioner providers in Arkansas →

Medicare billing

Part B allowed, 2024
$2,889
Medicare patients
23
Services billed
33

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Jonesboro

See the full list for Arkansas →

Where these figures come from

Is this you, or does something look wrong? →